Paul Edick '77 has been appointed chief executive officer of Durata Therapeutics, a biopharmaceutical company addressing the growing need for new antibiotics to treat infectious diseases.
Discussing his appointment, and that of Corey Fishman and Michael Dunne to the Durata leadership team, Edick said, "Each member of Durata's new senior team brings specific strengths and capabilities that will be critical to the organization. Corey has considerable operations and manufacturing background, as well as CFO expertise; Michael has led successful product development and regulatory efforts and has worked with dalbavancin, Durata's lead clinical asset; and I have had experience with building organizations, and multiple US and global product launches, which will be useful as we plan for further development and the potential commercialization of dalbavancin. I speak on behalf of all of us to say how excited we are to come together and lead Durata at this key moment in its evolution."
Edick has most recently been chief executive officer of GANIC Pharmaceuticals. Previously, he was CEO of MedPointe, Healthcare Inc. and held various senior executive positions at G.D. Searle and its acquirer, Pharmacia Corporation. He held sales management positions at Ortho Pharmaceuticals and general management positions at Hamilton Communications and Caremark.
At Hamilton, Edick studied psychology and participated in men’s swimming and diving.